BioCentury
ARTICLE | Emerging Company Profile

MorphoSys and 'combinatorial biology'

September 25, 1995 7:00 AM UTC

Combinatorial chemistry companies have proliferated like peptide libraries, and finding features that distinguish one from another has become an increasingly difficult endeavor. MorphoSys GmbH is taking a different tack, with technologies it describes as "combinatorial biology."

Although at least one other company has seized upon the "combinatorial biology" phraseology (see ChromaXome Corp. item, page B2), MorphSys' goal is to develop methods whereby mutagenesis can be harnessed to create desired compounds with only limited human intervention...